まとめ
血管切除は,血栓炎のリスクを増加させるようには見えません. 血液凝固検査は,小規模な術後の変化にもかかわらず,静脈切除された男性において血栓形成傾向を示さなかったし,血栓形成の臨床的兆候も観察されなかった.
科学分野:
- 血管外科 血管外科
- 血栓性合併症とは - コトバンク
- 男性の健康についてです.
背景:
- 血管切除術は,男性の不妊化のための一般的な外科的処置である.
- 血管切除術後の血栓炎症 (血栓形成による静脈炎症) の潜在的なリスクの増加に関する懸念があります.
- 血栓性合併症は,全身の股関節置換手術などの外科手術の既知のリスクです.
研究 の 目的:
- 精管切除術後の血栓塞栓炎のリスクを調査する.
- 精管切除術を受けた男性における凝固のパラメータを評価するために.
- 静脈切除手術を受けた男性の凝固プロフィールを,年齢に匹敵する対照群と,全体的な股関節置換手術を受けた患者の凝固プロフィールと比較するために.
主な方法:
- ヴァセクトミーを受けた58人の男性と37人の年齢相応の対照群を対象としたコホート研究.
- 結血のパラメータは,静脈切除された患者でモニタリングされました.
- 総合股関節置換手術を受けた8人の患者は,高リスク比較グループとして含まれていた.
主要な成果:
- 静脈切除を受けたグループでは,血栓性傾向を示唆する凝固の有意な変化は見られなかった.
- 手術前におけるフィブリノゲン濃度の上昇が認められた.
- 暫定的な術後のV因子濃度,プロトロンビン時間,およびフィブリノゲンの増加は,いくつかの静脈切除された患者で観察されました.
- 静脈切除手術を受けた患者は,血栓形成の臨床的証拠を示さなかった.
結論:
- 血管切除は,血栓形成炎のリスクの増加と関連しているようには見えない.
- 血管切除後に観察された凝固の変化は軽微で一時的なもので,血栓性傾向を示すものではありません.
- さらなる研究が必要かもしれませんが,現在の研究結果は,血管切除が血栓性合併症に関して安全であることを示唆しています.
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.


